Healthcare · Profile from Healthcare Research Companion
Ping An Good Doctor (Ping An Healthcare and Technology Company Limited)
China's best-known online consultation platform, built in 2014 inside the insurance and financial conglomerate Ping An. It used an in-house medical team plus AI triage to answer hundreds of millions of health questions. It listed in Hong Kong in May 2018 at a ~US$7.5bn valuation, then lost money for a decade. A traffic boom in the 2020 pandemic did not change the economics. Its founder was removed in 2020, and from 2021 it rebuilt itself as the healthcare and elderly-care service arm of Ping An's insurance business. It reported its first full-year profit in 2024. The lesson it teaches is that scale without a payer model does not produce profit, and that in China the payer it eventually found was its own parent.
At a glance
- Founded
- 2014, Shanghai, as a subsidiary of Ping An Insurance (Group) Company of China; the "Ping An Good Doctor" (平安好医生) app went live in 2015 (verify exact launch month)
- Founder
- Wang Tao (王涛), a former senior Alibaba executive who joined Ping An in 2013; chairman and CEO until his removal in May 2020
- Headquarters
- Shanghai, China
- Ownership / structure
- Listed on the Main Board of the Hong Kong Stock Exchange, stock code 1833 (IPO May 4, 2018); Ping An Group is the controlling and largest shareholder (~40%+, verify current stake). Legal name Ping An Healthcare and Technology Company Limited (中国平安健康医疗科技有限公司), incorporated in the Cayman Islands
- Leadership (2026)
- He Mingke, CEO and executive director (from October 7, 2025; former senior roles in finance, internet and healthcare, reported to include Baidu Health); Guo Xiaotao (Michael Guo), chairman (from October 7, 2025; also a joint CEO of Ping An Group, reported). Predecessors: Wang Tao (2014–2020), Fang Weihao (2020–2023), Li Dou (2023–2025)
- Segment and buyer
- Digital health and managed care services (global; China). Buyers: Ping An's insurance businesses and their policyholders (the "F-end", ~60% of revenue), corporate clients buying employee health management (the "B-end", ~24%), individual consumers, and seniors under elderly-care service packages
- Scale
- Registered users ~400m+ (company figure; registrations, not active users); ~50,000 in-house and contracted doctors (company figure, 2025); revenue RMB5.47bn (~US$0.76bn) in 2025, profit attributable to owners ~RMB380m (reported)
- Capital raised / valuation / market cap
- US$500m Series A at ~US$3bn valuation (2016, reported); US$400m from SoftBank Vision Fund for 7.41% (January 2018), implying ~US$5.4bn; IPO raised ~US$1.12bn at HK$54.80 (~US$7.5bn valuation, reported); market value rose sharply during the 2020 pandemic and peaked in early 2021 (verify level), then fell by roughly 80–90% by 2022–24 (verify)
- Signature moves (incl. failures)
- Launch inside Ping An with an in-house doctor team (2014–15); US$500m Series A (2016); AI "One-minute Clinics" (2017–19, quietly de-emphasised); SoftBank round and Hong Kong IPO (2018); Covid traffic surge (2020); founder ouster and leadership reset (2020); managed-care pivot and the forced "Ping An Health" app rename after a trademark loss (2021); retrenchment and first annual profit (2022–2024); AI doctors and return to the Good Doctor brand (2025)
9 strategic moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
2014
Launch Inside Ping An
Founding / launch
2016
Series A at 3B Valuation
Funding round
2017
One Minute Clinics
Launch / AI launch (later de-emphasised)
2018
SoftBank Round and Hong Kong IPO
Funding round / IPO
2020
Covid Traffic Surge
Demand shock / product scale-up
2020
Founder Ouster and Leadership Reset
Restructuring / leadership change
2021
Managed Care Pivot and Ping An Health Rename
Pivot / rebrand
2022
Retrenchment and First Profit
Restructuring / pivot
2025
AI Doctors and Brand Return
AI launch / rebrand / leadership change